World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
36503
World Ranking
8003
National Ranking
464

Overview

Burkhard Göke is affiliated with Ludwig-Maximilians-Universität München in Germany and has a research focus primarily in the field of Medicine. Within this broad domain, their work concentrates on subfields such as Endocrinology, Diabetes and Metabolism, Physiology, and Surgery.

The scientist's recent publications highlight a specialization in diabetes-related topics, including diabetes treatment, management, and pancreatic function. Key topics covered in their research include:

  • Diabetes Treatment and Management
  • Diabetes Management and Research
  • Diet and metabolism studies
  • Pancreatic function and diabetes
  • Diet, Metabolism, and Disease

Some notable recent papers authored or co-authored by Burkhard Göke are:

  • Die Behandlung des Diabetes mellitus: Mythen und Evidenz (2020), published in Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  • Glucagon receptor family in GtoPdb v.2023.1 (2023), published in IUPHAR/BPS Guide to Pharmacology CITE
  • Glucagon receptor family in GtoPdb v.2021.3 (2021), published in IUPHAR/BPS Guide to Pharmacology CITE
  • Glucagon receptor family in GtoPdb v.2025.3 (2025), published in IUPHAR/BPS Guide to Pharmacology CITE

The frequent co-authors collaborating with Burkhard Göke include:

  • D. Bataille
  • Susan L.F. Chan
  • Philippe Delagrange
  • Daniel J. Drucker
  • Rebecca Hills

Most of Göke's publications have appeared in the following journals:

  • IUPHAR/BPS Guide to Pharmacology CITE
  • Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Best Publications

  • Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.

    R Göke;H C Fehmann;T Linn;H Schmidt

  • Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man.

    R. Eissele;R. Göke;S. Willemer;H.-P. Harthus

  • Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

    Christine Herrmann;Rüdiger Göke;Gerd Richter;Hans-C. Fehmann

  • Glucagon-like peptide-1: a potent regulator of food intake in humans

    J P Gutzwiller;B Göke;J Drewe;P Hildebrand

  • Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide

    Hans-Christoph Fehmann;Rüdiger Göke;Burkhard Göke

  • Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2.

    Jean-Pierre Gutzwiller;Jürgen Drewe;Burkhard Göke;Burkhard Göke;Harald Schmidt

  • IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.

    Stephan Brand;Florian Beigel;Torsten Olszak;Kathrin Zitzmann

  • International Union of Pharmacology. XXXV. The Glucagon Receptor Family

    Kelly E. Mayo;Laurence J. Miller;Dominique Bataille;Stéphane Dalle

  • Gastric emptying and release of incretin hormones after glucose ingestion in humans.

    Jörg Schirra;Martin Katschinski;Claudia Weidmann;Thomas Schäfer

  • Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.

    A Graser;P Stieber;D Nagel;C Schäfer

  • Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.

    Julia Seiderer;Ira Elben;Julia Diegelmann;Jürgen Glas

  • Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

    Michael Lehrke;Alexander Becker;Martin Greif;Renee Stark

  • Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis.

    Frank T. Kolligs;Guido Bommer;Burkhard Göke

  • Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes: Importance of postprandial glycemia to achieve target HbA1c levels

    Hans J. Woerle;Christoph Neumann;Silvia Zschau;Stephanie Tenner

  • Glucose-Dependent Insulinotropic Polypeptide Is a Growth Factor for β (INS-1) Cells by Pleiotropic Signaling

    Andrea Trümper;Katja Trümper;Heidi Trusheim;Rudolf Arnold

  • Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7-36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides.

    Karin Hupe-Sodmann;Gerard Patrick McGregor;Robert Bridenbaugh;Rüdiger Göke

  • Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.

    J Schirra;K Sturm;P Leicht;R Arnold

  • Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans

    Jörg Schirra;Mathias Nicolaus;Rudolf Roggel;Martin Katschinski

  • The role of the novel Th17 cytokine IL-26 in intestinal inflammation

    J Dambacher;F Beigel;K Zitzmann;E N De Toni

  • IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression.

    Stephan Brand;Florian Beigel;Torsten Olszak;Kathrin Zitzmann

Frequent Co-Authors

Stephan Brand
Stephan Brand Ludwig-Maximilians-Universität München
Rudolf Arnold
Rudolf Arnold Philipp University of Marburg
Bertram Müller-Myhsok
Bertram Müller-Myhsok Max Planck Society
Jörg T. Epplen
Jörg T. Epplen Ruhr University Bochum
Helmut M. Diepolder
Helmut M. Diepolder Ludwig-Maximilians-Universität München
Alexander L. Gerbes
Alexander L. Gerbes Ludwig-Maximilians-Universität München
Maximilian F. Reiser
Maximilian F. Reiser Ludwig-Maximilians-Universität München
Christoph Beglinger
Christoph Beglinger University of Basel
Eckhard Wolf
Eckhard Wolf Ludwig-Maximilians-Universität München
John C. Morris
John C. Morris Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re planning to study Medicine in the USA, exploring related online degrees can broaden your career options and offer flexible learning paths. For those already in nursing or healthcare, accelerated online programs offer efficient ways to advance your qualifications.

One popular route is the 1 year dnp program online, which enables qualified nurses to quickly earn a Doctor of Nursing Practice in as little as twelve months. For those seeking flexibility, various dnp online programs offer accessible options that fit around work schedules and family commitments.

Students interested in fast-tracking their nursing careers may consider a 9 month lpn program. This allows individuals to enter the workforce sooner with the foundational skills needed for entry-level nursing roles.

Mental health professionals can also advance their careers efficiently through online programs, such as taking the msn to pmhnp online pathway for psychiatric mental health nurse practitioners.

By choosing the right online degree, you can find a career path that matches your goals, schedule, and interests while preparing for the dynamic field of medicine.

Best Scientists Citing Burkhard Göke

Trending Scientists

Recently Published Articles